Detalhe da pesquisa
1.
An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
Gastroenterology
; 162(1): 209-222, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34571027
2.
Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system.
Nat Commun
; 15(1): 2230, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472198
3.
Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer.
bioRxiv
; 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293113
4.
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
NPJ Precis Oncol
; 8(1): 87, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589664
5.
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.
Clin Cancer Res
; 30(8): 1669-1684, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345769
6.
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation.
Sci Adv
; 9(13): eadf0927, 2023 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989360
7.
Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors.
bioRxiv
; 2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034740
8.
Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors.
iScience
; 26(11): 108169, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965133
9.
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.
Nat Commun
; 14(1): 110, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611031
10.
YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.
Dev Cell
; 57(2): 212-227.e8, 2022 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990589
11.
Early TP53 Alterations Shape Gastric and Esophageal Cancer Development.
Cancers (Basel)
; 13(23)2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885025
12.
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma.
Clin Cancer Res
; 27(24): 6622-6637, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285063
13.
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.
Nat Genet
; 52(2): 219-230, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025000
14.
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.
NPJ Precis Oncol
; 8(1): 98, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710943
15.
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Cancer Cell
; 33(4): 721-735.e8, 2018 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622466
16.
Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma.
J Immunother Cancer
; 4: 26, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27099755